# The Effect of Remifentanil on ED95 of Remimazolam for Loss of Consciousness in Adult Patients

> **NCT05434494** · NA · UNKNOWN · sponsor: **Ajou University School of Medicine** · enrollment: 80 (estimated)

## Conditions studied

- Remimazolam

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** remifantanil

## Key facts

- **NCT ID:** NCT05434494
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2023-07-30
- **Final completion:** 2023-08-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05434494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05434494, "The Effect of Remifentanil on ED95 of Remimazolam for Loss of Consciousness in Adult Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05434494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*